Village Farms International (VFF) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual meeting scheduled for June 20, 2025, to be held virtually; shareholders of record as of May 9, 2025, are eligible to vote on key proposals.
Proposals include election of directors, advisory approval of executive compensation, and appointment of KPMG LLP as auditor for 2025.
Proxy materials, including the annual report and financial statements for 2024, are available online and by mail.
Forward-looking statements are included, subject to risks and uncertainties as detailed in regulatory filings.
Voting matters and shareholder proposals
Shareholders will vote on: (1) election of eight directors, (2) advisory approval of executive compensation, and (3) appointment of KPMG LLP as auditor and authorization of their remuneration.
Board recommends voting FOR all proposals.
Shareholder proposals for the 2026 meeting must be received by April 21, 2026, to be considered.
Shareholders may nominate directors or submit proposals under specific deadlines and requirements.
Board of directors and corporate governance
Board consists of eight directors, six of whom are independent under Nasdaq and Canadian standards.
Board committees include Audit and Risk, Compensation, and Corporate Governance and Nominating, all composed of independent directors.
Board mandate includes oversight of strategy, risk, management performance, and integrity of financial reporting.
Annual assessments of board and committee effectiveness are conducted.
Diversity is considered in director recruitment, with 33% of directors or executive officers identifying as female, visible minority, indigenous, or disabled.
Latest events from Village Farms International
- Record 2025 profit, strong cannabis sales, and expansions support future growth.VFF
Q4 202512 Mar 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20243 Feb 2026 - Record sales growth in Canadian cannabis and produce, but net loss widened by U.S. impairment.VFF
Q2 20242 Feb 2026 - Q3 sales up 20%, driven by Canadian cannabis, fresh produce, and international growth.VFF
Q3 202416 Jan 2026 - All director nominees and motions were approved, with final results to be published.VFF
AGM 20256 Jan 2026 - Full-year sales up 18% to CAD 336M; international medicinal sales to triple in 2025.VFF
Q4 202425 Dec 2025 - Plans to raise up to $200 million for growth via a multi-security shelf registration.VFF
Registration Filing16 Dec 2025 - Canadian Cannabis EBITDA up 64%, international exports up 285%, $40M produce asset sale.VFF
Q1 202526 Nov 2025 - Record Q2 profit, surging cannabis margins, and global expansion drive strong outlook.VFF
Q2 202523 Nov 2025